Journal article

Mutant TDP-43 Expression Triggers TDP-43 Pathology and Cell Autonomous Effects on Primary Astrocytes: Implications for Non-cell Autonomous Pathology in ALS

SK Barton, CL Lau, MDF Chiam, D Tomas, H Muyderman, PM Beart, BJ Turner

Neurochemical Research | SPRINGER/PLENUM PUBLISHERS | Published : 2020

Abstract

Motor neuron degeneration in amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1) is partly non-cell autonomous, involving cellular dysfunction of astrocytes. Whether non-cell autonomous effects occur in other forms of ALS, such as TAR DNA binding protein 43 (TDP-43)-related disease, remains unclear. Here, we characterised the impact of mutant TDP-43 expression on primary astrocytes derived from transgenic TDP-43A315T mice. Mutant TDP-43 astrocytes revealed evidence for TDP-43 pathology, shown by cytoplasmic TDP-43 inclusions and accumulation in insoluble cell fractions which was exacerbated by proteasomal inhibition. l-glutamate uptake, measured using an ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

PMB is pleased to contribute a paper to this Special Issue honouring Michael Robinson who has been a colleague furthering the neurochemical cause via Neurochemistry International and internationally (ISN) for some 20 years. Funding for this project was provided by the Australian NHMRC (Project Grant 1023780 P.M.B.; Fellowship 1020401 P.M.B.; Fellowship 1137024 B.J.T; and joint NHMRC-ARC Fellowship 1110040 S.K.B) and the Stafford Fox Medical Research Foundation. The Florey Institute of Neuroscience & Mental Health acknowledge Victorian Government Operational Infrastructure Support.